Doximity, Inc.
DOCS
$25.02
$0.311.26%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 637.78M | 621.33M | 589.64M | 570.40M | 550.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 637.78M | 621.33M | 589.64M | 570.40M | 550.17M |
| Cost of Revenue | 65.39M | 60.87M | 58.12M | 55.87M | 53.97M |
| Gross Profit | 572.39M | 560.46M | 531.52M | 514.53M | 496.19M |
| SG&A Expenses | 215.53M | 207.73M | 195.04M | 190.70M | 183.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 397.31M | 372.82M | 350.42M | 339.62M | 326.20M |
| Operating Income | 240.47M | 248.51M | 239.21M | 230.78M | 223.97M |
| Income Before Tax | 276.28M | 285.32M | 274.55M | 263.57M | 253.13M |
| Income Tax Expenses | 36.88M | 32.29M | 39.42M | 40.39M | 51.79M |
| Earnings from Continuing Operations | 239.40 | 253.03 | 235.13 | 223.19 | 201.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 239.40M | 253.03M | 235.13M | 223.19M | 201.35M |
| EBIT | 240.47M | 248.51M | 239.21M | 230.78M | 223.97M |
| EBITDA | 246.65M | 253.75M | 243.91M | 235.64M | 228.85M |
| EPS Basic | 1.27 | 1.35 | 1.25 | 1.19 | 1.08 |
| Normalized Basic EPS | 0.92 | 0.96 | 0.92 | 0.89 | 0.86 |
| EPS Diluted | 1.20 | 1.26 | 1.17 | 1.11 | 1.00 |
| Normalized Diluted EPS | 0.86 | 0.89 | 0.86 | 0.83 | 0.80 |
| Average Basic Shares Outstanding | 751.53M | 751.21M | 749.76M | 747.39M | 745.78M |
| Average Diluted Shares Outstanding | 804.11M | 807.12M | 806.79M | 804.85M | 802.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |